Significant advancements in immunotherapy, particularly T cell therapy, have been made during the last ten years. This technique, for example, makes use of T cells that have been engineered to express artificial chimeric antigen receptors (CARs), which are able to identify particular proteins expressed on the surface of tumor cells and quickly activate and kill those cells. Learn more: TCR-based therapies
